During the past decade, Leningrad Regional Clinical Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 17 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leningrad Regional Clinical Hospital" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "AOP Orphan Pharmaceuticals AG" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leningrad Regional Clinical Hospital" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Leningrad Regional Clinical Hospital" are "Non-Small Cell Lung Cancer" (5 trials), "Arthritis, Psoriatic" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Lupus Erythematosus, Systemic" (2 trials) and "ALK+ Advanced NSCLC" (1 trials). Many other conditions were trialed in "Leningrad Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Leningrad Regional Clinical Hospital" are "Drug" (40 trials), "Other" (5 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Gemcitabine" (4 trials), "Atezolizumab" (3 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Leningrad Regional Clinical Hospital" are 40 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Leningrad Regional Clinical Hospital". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Leningrad Regional Clinical Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Leningrad Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".